New Zealand markets open in 9 hours 26 minutes

Serina Therapeutics, Inc. (SER)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
9.35-0.40 (-4.15%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Total revenue
0
500
3,039
Operating expenses
Research development
1,567
1,573
3,799
Selling general and administrative
1,821
1,289
1,298
Total operating expenses
3,259
2,770
4,671
Operating income or loss
-3,259
-2,270
-1,632
Interest expense
297.581
15.878
3.094
Total other income/expenses net
4,662
-397.619
359.04
Income before tax
1,194
-2,682
-1,265
Income from continuing operations
1,194
-2,682
-1,265
Net income
1,194
-2,682
-1,265
Net income available to common shareholders
1,194
-2,682
-1,265
Basic EPS
0.55
-1.24
-0.58
Diluted EPS
0.14
-1.24
-0.58
Basic average shares
2,167
2,167
2,167
Diluted average shares
8,569
8,569
8,569